myelodysplastic syndromes

Showing NaN - NaN of 51

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

Recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Jan 23, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

Active, not recruiting
  • Acute Myeloid Leukemia
  • +17 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

Recruiting
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Darbepoetin Alfa
  • Tampa, Florida
    Moffitt Cancer Center
Nov 21, 2022

MDS Trial in United States (Lenalidomide, Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
  • +5 more
Sep 28, 2022

MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

Recruiting
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia
  • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
  • Standard of Care Chemotherapy
  • Tampa, Florida
    Moffitt Cancer Center
Sep 27, 2022

MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)

Active, not recruiting
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +65 more
Aug 19, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

Terminated
  • MDS
  • Myelodysplastic Syndromes
  • APR-548 + Azacitidine
  • Tampa, Florida
  • +3 more
Jul 20, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +94 more
Jun 9, 2022

MDS Trial in Tampa, Saint Louis, Seattle (CPX-351, Research skin biopsy, Research blood draw)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Tampa, Florida
  • +2 more
Apr 1, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

MDS Trial in Orlando, Tampa, Baltimore (SX-682)

Recruiting
  • Myelodysplastic Syndromes
  • Orlando, Florida
  • +2 more
Feb 18, 2022

MDS Trial in Worldwide (Luspatercept, Placebo)

Completed
  • Myelodysplastic Syndromes
  • Stanford, California
  • +73 more
Nov 19, 2021

MDS Trial in Tampa, Baltimore, Bronx (TEW-7197)

Completed
  • Myelodysplastic Syndromes
  • Tampa, Florida
  • +2 more
Sep 22, 2021

Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)

Completed
  • Non-Hodgkin's Lymphoma
  • +7 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021

MDS Trial in Tampa (cenersen, Dexamethasone)

Terminated
  • Myelodysplastic Syndromes
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Feb 18, 2021

MDS Trial in Canada, United States (anti-thymocyte globulin)

Completed
  • Myelodysplastic Syndromes
  • anti-thymocyte globulin
  • Washington, District of Columbia
  • +27 more
Jan 24, 2021

MDS Trial in Germany, United States (Best Supportive Care, BI 836858)

Terminated
  • Myelodysplastic Syndromes
  • Best Supportive Care
  • BI 836858
  • Jacksonville, Florida
  • +4 more
Dec 18, 2020

Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Malignant Plasma Cell Tumors Trial in Tampa (busulfan,

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute at Universit
Dec 9, 2020

Quality of Life in Older vs. Younger Adult Patients Undergoing

Completed
  • Myelodysplastic Syndromes
  • Hematopoietic Cell Transplant
  • ePRO survey
  • Stanford, California
  • +5 more
Nov 30, 2020

MDS Trial in United States (ARRY-614, p38/Tie2 inhibitor; oral)

Completed
  • Myelodysplastic Syndromes
  • ARRY-614, p38/Tie2 inhibitor; oral
  • Tampa, Florida
  • +3 more
Sep 4, 2020